Will sunitinib be reimbursed by medical insurance?

Sunitinib (Sunitinib) is used to treat adults with the following types of cancer, including gastrointestinal stromal tumor (GIST), a cancer of the stomach and intestines in which cells grow uncontrolled in the supporting tissues of these organs. Sunitinib is used in patients with gastrointestinal stromal tumors that cannot be removed with surgery or has spread to other parts of the body, after treatment with imatinib (another cancer drug) has failed. It is also used in patients with metastatic renal cell carcinoma, a type of kidney cancer that has spread to other parts of the body, and pancreatic neuroendocrine tumors (tumors of the hormone-producing cells in the pancreas) that have spread or cannot be removed with surgery. Sunitinib is used if the disease progresses and the tumor cells are well differentiated (similar to normal cells in the pancreas). This drug is only available with a prescription.

The original sunitinib drug marketed in China has entered the scope of Class B medical insurance, and its specificationsThe price of 12.5mg*28 tablets is about 3,500 yuan. The reimbursement ratio is different in different regions, and the price after reimbursement is different.Sunitinib may be sold in pharmacies or hospitals. The original sunitinib drug has also been launched overseas. The price of 12.5mg*7 tablets is around RMB 1,500 (the price may fluctuate due to the exchange rate). There are also generic drugs produced in other countries. The price of 12.5mg*28 tablets produced by Du Pharmaceutical Factory is around RMB 750 (the price may fluctuate due to the exchange rate). The generic drugs produced abroad are basically the same as the domestic and foreign original drugs. The prices of drugs of different specifications may be different.